Drs. Dutton and Daughters contributed equally to this work.
Special Issue Techniques
Use of adenovirus for ectopic gene expression in Xenopus
Article first published online: 30 MAR 2009
Copyright © 2009 Wiley-Liss, Inc.
Special Issue: Special Focus on Xenopus
Volume 238, Issue 6, pages 1412–1421, June 2009
How to Cite
Dutton, J. R., Daughters, R. S., Chen, Y., O'Neill, K. E. and Slack, J.M.W. (2009), Use of adenovirus for ectopic gene expression in Xenopus. Dev. Dyn., 238: 1412–1421. doi: 10.1002/dvdy.21932
- Issue published online: 12 MAY 2009
- Article first published online: 30 MAR 2009
- Manuscript Accepted: 21 FEB 2009
- Wellcome Trust. Grant Number: 60082
- NIH. Grant Number: T32 AR050938
- University of Minnesota
- green fluorescent protein;
- Coxsackie and Adenovirus Receptor (CAR)
We show that replication defective adenovirus can be used for localized overexpression of a chosen gene in Xenopus tadpoles. Xenopus contains two homologs of the Coxsackie and Adenovirus Receptor (xCAR1 and 2), both of which can confer sensitivity for adenovirus infection. xCAR1 mRNA is present from the late gastrula stage and xCAR2 throughout development, both being widely expressed in the embryo and tadpole. Consistent with the expression of the receptors, adenovirus will infect a wide range of Xenopus tissues cultured in vitro. It will also infect early embryos when injected into the blastocoel or archenteron cavities. Furthermore, adenovirus can be delivered by localized injection to tadpoles and will infect a patch of cells around the injection site. The expression of green fluorescent protein in infected cells persists for several weeks. This new gene delivery method complements the others that are already available. Developmental Dynamics 238:1412–1421, 2009. © 2009 Wiley-Liss, Inc.
Methods for introducing new genes or gene products into organisms represent an extremely valuable technology in developmental biology. Such methods, generally referred to as “overexpression” or “ectopic expression,” can be used to establish the biological activity of gene products in vivo. They can also often be used to bring about ablation of a specific gene product, for example by expressing dominant-negative versions of gene products (Lagna and Hemmati-Brivanlou,1998) or RNAi constructs (Li and Rohrer,2006). To enable these techniques to be used to their maximum effect, it should be possible to overexpress a specific gene at any desired position and any desired stage of a developing organism. Overexpression techniques of various types exist for all of the main laboratory organisms for developmental biology research, although for each there are limitations on what is possible (Slack,2005). Xenopus is one of these systems (Sive et al.,2000). In the past, the main overexpression technique used has been the injection of synthetic mRNA into fertilized eggs or early cleavage stage blastomeres (Krieg and Melton,1984). This has proved an extraordinarily valuable method and has contributed to countless studies of early developmental mechanisms in the past 20 years. But there are two limitations. First, the mRNA starts being translated from the time of its injection and its effects on early developmental stages may compromise the embryo at later stages, although this can sometimes be overcome by using a fusion protein of the gene product of interest with the hormone binding domain of a nuclear hormone receptor (Kolm and Sive,1995). Second, the mRNA has a limited lifetime and it will decay over a period of some hours or days, depending on its intrinsic stability to nuclease digestion. Since 1996, RNA-based overexpression has been joined by some effective methods of transgenesis which enable DNA to be integrated into the entire organism. The original Kroll-Amaya method involves introduction of DNA into sperm, while the more recently published ones introduce DNA into fertilized eggs (Kroll and Amaya,1996; Amaya and Kroll,1999; Allen and Weeks,2005; Ogino et al.,2006; Pan et al.,2006). Transgenesis in Xenopus has overcome the limitations of mRNA stability and has opened up the phases of organogenesis, regeneration, and metamorphosis to further study by specific gene overexpression. However, the preparation of transgenics is still demanding and to get long-term survival of transgenic tadpoles requires very good egg quality and considerable skill on the part of the experimenter.
For many applications related to the study of late development, it is required to introduce a gene or gene product just into a specific location at a specific time. Here, we examine the feasibility of using adenoviral vector as a gene delivery system. Adenovirus is a nonenveloped, double-stranded DNA virus with an icosahedral coat composed mainly of three proteins called hexon, penton, and fiber. From the parent virus have been derived several generations of gene therapy vectors which have been widely used in mammalian systems and to some extent in human clinical trials (Gardlik et al.,2005; Verma and Weitzman,2005). Adenovirus can infect either dividing or nondividing cells. It introduces double-stranded DNA into the infected cell. which is expressed for some days or even weeks, but does not become integrated into the genome. The form of virus used for gene introduction is infectious but cannot replicate in the host cells because essential functions have been deleted from its genome. This is produced using a packaging cell line that contains the missing genes and can complement the defect, allowing for the production and release of active virus particles. The most commonly used adenoviral vector is human adenovirus serotype 5, which is rendered replication-defective by the deletion of the E1 and E3 genes. The E1 gene is essential for the assembly of infectious virus particles and is supplied by the packaging cell line. The E3 gene encodes proteins involved in evading host immunity and is dispensable. In addition to rendering the virus incapable of replicating itself, these deletions also create space for an insert of up to 7.5 kb. It has already been shown that adenovirus can infect Xenopus and introduce functional genes (Kawakami et al.,2006), but this study was in the context of many other experiments on several model organisms, and limited technical and background information was given for the use of adenovirus in Xenopus.
We show here that adenoviral vector is able to infect Xenopus and to express its transgene for a prolonged period in the host. It can be administered by localized injection and cause overexpression of the gene of interest in a small patch of tissue. For infection of tadpoles, a temperature increase is needed during the infection phase but not thereafter. Despite the lack of integration into the nuclear genome, gene expression continues for several weeks following the initial infection. We believe that this technique will complement the existing methods of gene overexpression, such as RNA injection, transgenesis and electroporation, and will prove to be a convenient route for studying the effects of localized overexpression of tissue specific genes in Xenopus.
Identification of Two Xenopus Adenovirus Receptors
Initially we did not know whether adenovirus could infect amphibian cells. The normal mechanism of infection for mammalian cells involves binding of virus to the Coxsackie and Adenovirus Receptor (CAR) an immunoglobulin superfamily member that mediates homotypic cell adhesion and is located in epithelial tight junctions, although it is also present on nonepithelial cell types (Bergelson et al.,1997; Philipson and Pettersson,2004). The existence of a zebrafish homolog of CAR (Petrella et al.,2002) made it likely that Xenopus would also contain one. Bioinformatic searching led to the identification of two CAR homologues now called xCAR1 and xCAR2 (Xenopus laevis Coxsackievirus and Adenovirus Receptors). xCAR1 was identified from a cDNA clone derived from a stage 24 embryo expressed sequence tag (EST) library and was sequenced in full. The coding region was then amplified by polymerase chain reaction (PCR) and was cloned into the expression vector pcDNA3.0. The other CAR homolog, xCAR2, was identified by blast sequence homology to human CAR from the NCBI Xenopus EST database. The coding sequence region was amplified by PCR from whole stage 20 embryo cDNA and cloned into pcDNA3.0.
Nucleotide sequence analysis and amino acid prediction were performed using the standard bioinformatics tool set through the NCBI database. Amino acid alignment of both xCAR1 and xCAR2 with other vertebrates demonstrated low level sequence homology across species with an overall identity of xCAR1 to human CAR of 38% and of xCAR2 of 53% at the protein level (Fig. 1A). This relatively low identity would not in itself suggest that the proteins function as adenoviral receptors. However, structural studies have shown that the virus binds by means of its fiber protein to the N-terminal domain of the CAR (Bewley et al.,1999). Figure 1B depicts the contact surface of the CARs deduced from structural analysis of the human molecule, with Xenopus residues shown color coded for similarity to the human. In this critical region, amino acid conservation of xCAR1 (66%) and xCAR2 (70%) is very high, and it therefore seemed likely that both of the xCAR molecules would be able to support infection of Xenopus cells by adenovirus.
To confirm the predicted biological activity of the two receptors, we transiently transfected the full-length xCAR1 and xCAR2 into Chinese hamster ovary (CHO) cells, which have no CAR of their own (Graham and Prevec,1992), and then tested for infectability with adeno-GFP at various multiplicities of infection. Green cells became visible in all the wells transfected with xCAR1 and xCAR2, but not in controls, at a frequency similar to the overall transfection frequency, indicating that both xCARs can support virus entry to cells (Fig. 2). Analysis of the cells by flow cytometry showed that the transfection efficiency is approximately 5% and that essentially all of the cells transfected with xCARs became infected by the adeno-GFP.
An expression analysis of xCAR1 and xCAR2 was conducted by reverse transcriptase-PCR (RT-PCR; Fig. 3A). This showed that xCAR1 mRNA is expressed from mid-gastrulation onward, while xCAR2 mRNA is present at all stages, presumably therefore being both maternal and zygotic. Tissues dissected from stage 54–56 tadpoles all express xCAR1 and xCAR2, suggesting that susceptibility to adenovirus expression is widespread (Fig. 3B). Whole-mount in situ hybridization of embryos also confirmed widespread expression (Fig. 3C–H). The pattern seen is typical of ubiquitously expressed genes, although there is some minor additional expression of xCAR2 in the pronephros and in the neural part of the tail bud.
Infection of In Vitro Cultures
Because in vivo administration of gene therapy vectors is often limited by access to the virus receptors on cell surfaces, we first tested for infectability of Xenopus cells in vitro. The cells were grown from explanted tissues cultured in L15 medium, either on fibronectin-coated plastic or on Millipore filters. We found that a wide range of tissues could be infected. The GFP expression became visible from approximately the 3rd day and persisted for at least 7 days after this. Figure 4 shows infection of cell types characteristic of all three germ layers, including cells with morphology corresponding to neurons, fibroblasts, and epithelial cells. The time to appearance of the GFP is approximately twice what would be expected in mammalian cells, a difference probably attributable to the lower temperature used for the Xenopus cultures (28°C instead of 37°C).
Infection of Embryos and Tadpoles
Initial in vivo experiments were conducted by injecting the virus into the blastocoel or archenteron of early stage embryos. The injections were not associated with any noticeable mortality or morbidity and GFP fluorescence was seen to develop approximately 3 days later. It was present in many tissues at many positions within the later tadpoles (Fig. 5). The fluorescence persisted for at least 10 days without diminution of intensity. Table 1 shows the percentages of tadpoles labeled in different tissues after injection at different stages. High proportions of muscle labeling arise from injection of stage 8 blastulae, high proportions of intestinal labeling from injection of gastrulae, and overall infection at early neurula stage seemed less effective. These differences probably reflect the accessibility of the prospective regions for the tissues in question rather than any major difference in the susceptibility of different tissues. In the blastula stage, many cells lining the blastocoel will later contribute to trunk and tail muscles (Dale and Slack,1987). In the gastrula, the cells lining the archenteron will later end up in the intestine (Chalmers and Slack,2000). In the neurula stage, the archenteron cavity is connected to the exterior by a patent blastopore, so some of the injected virus may leak out, reducing the effective dose. In these experiments, no labeling was seen in the central nervous system. This is probably due to limited access at the stages of injection as the in vitro experiments indicate that neurons can be infected.
|Stage injected||Jaw muscle||Brain||Heart||Liver||Stomach||Small intestine||Large intestine||Trunk/tail muscle||No GFP|
|Stage 8 (n = 30)||6.7||6.7||30||13.3||0||16.7||0||90||3.3|
|Stage 10.5 (n = 108)||8.3||0.9||6.5||3.3||0||73.5||1.9||12.0||16.6|
|Stage 12 (n = 73)||0||0||1.4||0||0||80.1||5.4||5.4||11|
|Stage 14 (n = 74)||8.5||7||2.8||0||12.7||19.7||9.9||11.3||74.6|
To find whether the long lifetime of the fluorescence was due to persistence of active virus or simply to the stability of the GFP protein, we compared the persistence over 10 days of GFP RNA and fluorescence following either injection of RNA to cleaving embryos, or injection of adeno-GFP to blastulae (Table 2; Fig. 5G). The RNA injections show, as expected, that the RNA is mostly gone by 3 days, while the GFP fluorescence persists in over half the embryos for 7 days. By contrast, the virus injections show that both RNA and protein persist at a high level for at least 10 days. This shows that the virus remains active for at least this period, and probably for much longer.
|Reagent||n||Stage injected||Days post-injection|
|RNA||%GFP+||GFP intensity||RNA||%GFP+||GFP intensity||RNA||%GFP+||GFP intensity||RNA||%GFP+||GFP intensity|
|GFP RNA||120||2-cell intracellular||++++||96||++++||+||95||+++||−||68||++||−||28||+|
|Ad-GFP||120||Stage 8 blastocoel||−||0||−||++||92||+++||++||91||+++||++||89||+++|
Initial trials of localized injections into tadpoles gave no GFP expression at all. After some trial and error, success was obtained by keeping the tadpoles at an elevated temperature of 34°C overnight (16 hr), immediately after the virus injection. Although adenovirus usually functions at 37°C, we know that virus infection can occur at lower temperatures as shown by the early embryo experiments. The successful infection of tadpoles may require the higher temperature both to facilitate the virus–cell interaction and to expose the xCAR on cell surfaces. The overnight elevated temperature did not cause any deaths or obvious abnormalities among the tadpoles, nor was there any visible toxicity or damage arising from the presence of the virus at the injection site. Figure 6 and Table 3 show localized injection of both limb buds and of the tail. The muscle fibers are obviously infected as shown by the whole-mount view. The sections of the limbs show that connective tissue cells are also infected, although the cartilages are not. This may be because of access problems as the cartilages are surrounded by dense connective tissue sheaths. Following these localized injections into tadpoles the GFP typically takes approximately 5 days to appear, and it then persists for at least 4 weeks.
|Injection site||No. of injected tadpoles||No. of GFP-expressing tadpoles|
|Tail muscle||27||25 (92.6%)|
Although mostly associated in the past with studies of early development, Xenopus has recently also become a useful model organism for investigations of organogenesis, regeneration, and metamorphosis (Sive et al.,2000; Brown and Cai,2007; Slack et al.,2008). This means that there will be an increasing demand for methods of gene introduction at specific times and positions chosen by the experimenter. Injection of RNA or antisense morpholinos into specific blastomeres of early embryos have proved extremely useful for the study of early development, but inevitably the injected materials decay, and after 3 or more days of development their limited persistence becomes an issue. At present, the methods available for localized overexpression are the use of specific promoters for transgenesis, the performance of grafts of transgenic tissue to wild-type hosts, and electroporation.
Spatial control of transgene expression can be achieved by the use of tissue-specific promoters, which need not be of Xenopus origin (Beck and Slack,1999). Temporal control can be achieved by the use of the hsp70 promoter, which becomes active at 34°C and provides a tight regulation between active and inactive states (Wheeler et al.,2000). But it has not so far proved possible to combine these techniques to achieve tissue specific induction at a desired time. Some studies have shown the feasibility of binary transgenic techniques previously used in other model organisms. The Cre-lox system in its gene-activating mode has been adapted from mice (Werdien et al.,2001; Ryffel et al.,2003; Gargioli and Slack,2004; Waldner et al.,2006). Two constructs need to be introduced. One carries the gene for the Cre recombinase driven by a promoter of choice. The other carries the gene of interest whose expression will be activated by Cre activity. The Gal4 system has been adapted from its original use in Drosophila (Brand and Perrimon,1993) to Xenopus (Chae et al.,2002; Hartley et al.,2002). Again, two constructs are introduced, a specific promoter driving production of the yeast transcription factor Gal4, and the gene of interest driven by the specific upstream activating sequence (UAS), which is recognized and bound by Gal4. Either of these systems can be enhanced by the use of hormone inducible forms of the Cre (Hayashi and McMahon,2002) or Gal4 (Chae et al.,2002), which confers inducibility by the addition of the appropriate hormone. The fusion protein is sequestered in the cytoplasm by endogenous heat shock proteins and thereby kept in an inactive configuration. When the hormone is added to the embryos, it binds to the receptor, liberates the fusion protein from the complex, and enables it to perform its function (Kolm and Sive,1995). The tetracycline system (Gossen and Bujard,1992; Urlinger et al.,2000) has also been applied to Xenopus (Das and Brown,2004). The version used is the Tet-on system where addition of doxycycline activates transgene expression. All three of these binary systems show promise, but they do not necessarily function well with new gene combinations, and further development work is needed before they become generally accepted.
Spatial regulation of overexpression can also be achieved by using grafts from donors that are transgenic for ubiquitously expressed transgenes, or those driven by the hsp70 promoter. This has been used for the study of cell lineage in tail regeneration (Gargioli and Slack,2004; Lin et al.,2007), but there are limits on what is possible. Because of the physical properties of the tissues, it is much easier to make grafts at embryonic than at tadpole stages, and so the shape and size of the final genetically modified domain is not easy to control.
The transgenic methods are all demanding because they require complex interventions at early embryonic stages, followed by successful cultivation of tadpoles to the required stage for the experiments. For this reason, electroporation of plasmid DNA has been used in some studies, mostly involving the central nervous system (Eide et al.,2000; Haas et al.,2002; Echeverri and Tanaka,2003; Falk et al.,2007). Like virus infection this has the potential advantage that it can be carried out on normal tadpoles that are taken from a stock population and have had no previous treatments. But a recognized problem with electroporation is that it can cause instability of cell differentiation state (Atkinson et al.,2006). Also we have noticed a tendency for tadpoles to die of stopped heart when the electrodes are in the vicinity of the heart.
Given the problems with electroporation, we think that there is also a role for the use of viral vectors in overexpression experiments. Adenovirus is easy to prepare and can be stored at −80°C before use. Its administration requires no equipment other than that already present in Xenopus laboratories. We have noticed that the development of GFP fluorescence is quite slow following virus infection. This probably indicates introduction of a relatively small number of DNA molecules per cell, and suggests that the virus method is a benign one that does not cause damage to infected cells. In fact, we have not noticed any ill effects or deaths among virus-infected tadpoles. Despite the nonintegration into the genome, the duration of adenoviral mediated overexpression is very long and is likely to be long enough for any experiment on Xenopus tadpoles. If integration into genomic DNA were essential for a particular experiment then adenovirus would not be suitable and an integrating viral vector such as lentivirus would be necessary. So far, there are only a few studies on the use of lentivirus in Xenopus, and they are all in vitro rather than on whole embryos or tadpoles (Gatlin et al.,2001; Sugiyama et al.,2005). But these studies do show that Xenopus cells can be infected and suggest that lentivirus may also prove useful for localized overexpression at late stages.
Until a few years ago the preparation and use of viral gene therapy vectors such as adeno- or lentivirus, was a specialized activity that had to be carried out by virology labs. Today, however, there are kits available to construct and expand the viruses, and their use requires just normal molecular and cell biology skills. There are also companies that will perform the construction and amplification of adenovirus for a fee. These technical advances mean that this new method of specific gene overexpression should be readily available to developmental biology labs in future.
A first-generation, replication-defective, recombinant adenoviral vector was used in these experiments. Ad-RSV-GFP (here called adeno-GFP) was propagated in the E1-containing human embryonic kidney (HEK) cell line 293 (Graham and Prevec,1992). HEK 293 cells were maintained in Dulbecco's modified Eagle medium (Invitrogen) supplemented with 10% heat-inactivated fetal calf serum (Sigma). The virus was grown to high titer, released from the cells by rapidly freeze/thawing 3 times and then purified twice by cesium chloride density ultracentrifugation. The buffer was exchanged with 10 mM Tris.HCl pH 7.5, 1 mM MgCl2 on a PD-10 Sephadex column (Amersham Biosciences), before the virus was passed through a sterile 0.22 μm Millex filter (Millipore) and frozen in 10-μl aliquots using dry ice. The viral stocks were stored at −80°C. The titer of the vector was 3 × 1010 infectious units/ml, which was calculated using the Adeno-X Rapid Titer Kit (Stratagene). Virus was prepared and used under BSL2 safety conditions.
Two homologues (xCAR1 and xCAR2) of the human coxsackie and adenovirus receptor were identified as cDNA clones from NCBI gene database with accession number AW782510 and AW638467, respectively. Clone AW782510 was obtained from the RZPD (Deutsches Ressourcenzentrum für Genomforschung) and sequenced in full. A 1,158-bp xCAR1 coding sequence was amplified by PCR using Vent polymerase (New England Biolabs) using 5′primer (5′-CGAAGATGGAAGAACGGAGGATCTC-3′) and 3′primer (5′-CGCTCGAGCCTGGATCTAAGGACTATC-3′). The entire 1,044-bp coding sequence for xCAR2 was amplified from whole stage 20 embryo cDNA using the 5′primer (5′-CCCAAGCTTTACACCCGGAGCTTAGCACT-3′) and the 3′primer (5′-CCGCTCGAGGGTCAACGAGGCACTTTCAT-3′). The resulting PCR fragments were digested with IHindIII and XhoI and inserted into the mammalian expression vector pcDNA3 (Invitrogen) and confirmed by sequencing.
CHO Cell Culture and Adeno-GFP Infection
CHO-K-1 cells were purchased from the ATCC and grown in DMEM supplemented with 10% fetal bovine serum (FBS), penicillin and streptomycin at 37°C in 5% CO2. Cells were plated at 4 × 105 cells per well of a 12-well plate and transfected with xCAR1 or xCAR2 using Lipofectamine 2000 reagent (Invitrogen) according to the manufacturer's instructions, using 2 μg of plasmid DNA per well. Adeno-GFP was added to the medium 24 hr after transfection at a multiplicity of approximately 25 virus particles per cell, and incubated for 12 hr. GFP-positive cells were examined and photographed 72 hr after virus infection. To quantify the result, the cell populations were analyzed by flow cytometry using a FACS Calibur. Cells were stained with propidium iodide (PI) and the threshold GFP fluorescence was determined for the untreated CHO cells. Then cells were counted for low PI (to confirm viability) and GFP fluorescent intensity.
Embryos and Tadpoles
Xenopus laevis embryos were obtained by in vitro fertilization and staged according to the Nieuwkoop and Faber (NF) tables (Nieuwkoop and Faber,1967). Embryos were dejellied with 2% cysteine (Sigma), pH 7.8, and then cultured in 0.1 × NAM. From stage 46, they were fed on tadpole diet (NASCO).
Early stage Xenopus embryos were arranged in a slit cut in a thin layer of agar in a 90-mm Petri dish and all medium was removed. Adeno-GFP + 1% phenol red was front loaded into glass microinjection needles using a Nanoject II microinjector (Drummond) and known volumes injected directly into individual embryos. Capped nGFP mRNA, used for controls on mRNA and protein stability, was in vitro transcribed using T7 mMessage mMachine kit (Ambion) according to the manufacturer's instructions.
Late stage tadpoles (around stage 54 to stage 56) were anesthetized in 0.02% MS222 and kept in the anesthetic solution during adenovirus injection. Adeno-GFP was injected into the tail muscle (approximately 1 μl) and limbs (9.2 nl) of each tadpole using a Nanoject injector. After the injection, the tadpoles were incubated in 0.1× MMR at 34°C for 16 hr and then transferred to a 25°C incubator.
In Vitro Cell and Explant Organ Culture
Embryonic X. laevis neural tube explants were performed by dissecting the neural tube from embryos before neural crest migration and plating them onto fibronectin-coated plastic dishes. Endodermal organ cultures were performed following dissection of the relevant structures from tadpoles, washing them extensively in 70% L15 medium supplemented with gentamycin (2.5% of Sigma stock) before placing them on permeable CM membrane culture filters (Millipore) in dishes of culture media. The culture conditions were 70% L15 media supplemented with 5% fetal bovine serum, 1% penicillin/streptomycin, 1% amphotericin, and 2.5% gentamycin. The explants were grown at 28°C in air and the medium was changed every other day. Adeno-GFP infection was performed by adding virus diluted in culture medium directly to the organs in culture.
Gene Expression Analysis
RNA was isolated from stage 2 to 45 whole embryos or from dissected stage 54/56 Xenopus organs using TriReagent (Sigma) according to the manufacturer's instructions. 1 μg of DNAseI-treated total RNA was reverse transcribed using SuperScriptII (Invitrogen). PCR was performed with primers specific for xCAR1 [RSD1061 5′-GAGGCGATTGTCATTCAGT-3′and RSD1062 5′-CCCATTTGTAACTGAGAG-3′(Tm 56)], xCAR2 [RSD1059 5′-GTCTCCAATGACCCCAAGAC-3′ and RSD1060 5′-CACCTCGTTTTTGCTGGTTT-3′(Tm 58)], and xEf1α [RSD1065 5′-CAGATTGGTGCTGGATAT-3′ and RSD1066 5′-ACTGCCTTGATGACTCCTAG-3′ (Tm60)] for 30 cycles.
Whole-mount in situ hybridization was performed according to the standard protocol (Harland,1991). Both pcDNA3-xCAR1 and pcDNA3-xCAR2 were linearized with HindIII and transcribed in the presence of digoxigenin (DIG)-UTP with SP6 RNA polymerase to produce full-length DIG-labeled antisense probes followed by hydrolysis to increase probe penetration. Embryos were incubated overnight at 58°C in 1 μg of probe. Probes were visualized using an anti–DIG-AP Fab fragment antibody (Roche;1/2,000) incubated overnight at 4°C and developed with BM purple reagent (Roche).
The stability of GFP transcripts was determined by RT-PCR on mRNA obtained from stage 2 GFP-mRNA (1 ng) injected or stage 8 blastocoel Ad-GFP (2.3 nl) -injected embryos at 1, 3, 7, and 10 days after injection. RNA was isolated from whole embryos or tadpoles using TriReagent (Sigma) according to the manufacturer's instructions. One microgram of DNAseI-treated total RNA was reverse transcribed using SuperScriptII (Invitrogen). PCR was performed with primers specific for GFP [GFP-C 5′-CATGGTCCTGCTGGAGTTCGTG-3′and GFP-N 5′-CGTCGCCGTCCAGCTCGACCAG-3′ (Tm 56)] and xEf1α [RSD1065 5′-CAGATTGGTGCTGGATAT-3′ and RSD1066 5′-ACTGCCTTGATGACTCCTAG-3′ (Tm 60)] for 25 cycles. GFP fluorescence intensity was assessed in vivo using the GF2 filter on a Leica dissecting microscope and acquired with a Qimaging Retiga 2000R camera. Percent GFP-positive numbers were determined from the number of embryos or tadpoles with observable GFP signal when photographed using the same acquisition parameters on all observation days. Both RNA and GFP signal intensity were ranked on a scale of not detectable (−) to maximum signal detected (++++).
Antibody Staining and Microscopy
Cells and tissue explants were fixed in Zamboni's fixative (40 mM Na2HPO4, 120 mM NaH2PO4, 2% paraformaldehyde, and 0.1 % saturated picric acid) for 20 min at room temperature, washed with phosphate buffered saline (PBS) and incubated in PBS with 1% Triton X-100 for 30 min. After blocking in 1× blocking reagent (Roche) dissolved in PBS 0.1% Triton X-100 for 1 hr at room temperature the primary antibody was applied in blocking solution overnight at 4°C. Secondary antibodies were obtained from Molecular Probes and incubated for 60 min at room temperature. Primary antibodies used were: rat anti–E-cadherin (Transduction Laboratories 1:400 dilution) and mouse monoclonal anti-smooth muscle actin (Sigma, 1:100).
The limbs with GFP expression were fixed in Zamboni's fixative and then sectioned transversely with a cryostat. The sections were double immunostained with anti-GFP (Abcam) antibody at 1:500 dilution and 12/101 antibody (muscle-specific, Developmental Studies Hybridoma Bank, 1:100 dilution. Their secondary antibodies were fluorescein-conjugated anti-rabbit IgG (Vector labs) and Alexa Fluor 594 anti-mouse IgG (Invitrogen), respectively.
GFP expression in tadpoles and organ explants was observed using a Leica MZ16F microscope. Pictures were taken with a Qimaging Retiga 2000R camera and presented using Photoshop (Adobe). Some in vitro cultures were also photographed using a Zeiss LSM510 confocal microscope.
We thank Dr. Mark Hornsey for preparing the virus and to Genya Gekker for assistance with flow cytometry. R.S.D. received a NIH Training Grant “Musculoskeletal Training Grant.”
- 2005. Transgenic Xenopus laevis embryos can be generated using phi C31 integrase. Nat Methods 2: 975–979. , .
- 1999. A method for generating transgenic frog embryos. Methods Mol Biol 97: 393–414. , .
- 2006. Cellular electroporation induces dedifferentiation in intact newt limbs. Dev Biol 299: 257–271. , , , , , .
- 1999. Gut specific expression using mammalian promoters in transgenic Xenopus laevis. Mech Dev 88: 221–227. , .
- 1997. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275: 1320–1323. , , , , , , , , .
- 1999. Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR. Science 286: 1579–1583. , , , , .
- 1993. Targeted gene-expression as a means of altering cell fates and generating dominant phenotypes. Development 118: 401–415. , .
- 2007. Amphibian metamorphosis. Dev Biol 306: 20–33. , .
- 2002. Inducible control of tissue-specific transgene expression in Xenopus tropicalis transgenic lines. Mech Dev 117: 235–241. , , .
- 2000. The Xenopus tadpole gut: fate maps and morphogenetic movements. Development 127: 381–392. , .
- 1987. Fate map for the 32 cell stage of Xenopus laevis. Development 99: 527–551. , .
- 2004. Controlling transgene expression to study Xenopus laevis metamorphosis. Proc Natl Acad Sci U S A 101: 4839–4842. , .
- 2003. Electroporation as a tool to study in vivo spinal cord regeneration. Dev Dyn 226: 418–425. , .
- 2000. Electroporation-mediated gene transfer in free-swimming embryonic Xenopus laevis. FEBS Lett 486: 29–32. , , .
- 2007. Electroporation of cDNA/morpholinos to targeted areas of embryonic CNS in Xenopus. BMC Dev Biol 7: 107. , , , , , , .
- 2005. Vectors and delivery systems in gene therapy. Med Sci Monit 11: RA110–RA121. , , , , , .
- 2004. Cell lineage tracing during Xenopus tail regeneration. Development 131: 2669–2679. , .
- 2001. Efficient, long-term transgene expression in Xenopus laevis dermal melanophores. Pigment Cell Res 14: 275–282. , , , .
- 1992. Tight control of gene-expression in mammalian-cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 89: 5547–5551. , .
- 1992. Adenovirus-based expression vectors and recombinant vaccines. Biotechnology 20: 363–390. , .
- 2002. Targeted electroporation in Xenopus tadpoles in vivo - from single cells to the entire brain. Differentiation 70: 148–154. , , , , .
- 1991. In situ hybridization: an improved whole-mount method for Xenopus embryos. Methods Cell Biol 36: 685–695. .
- 2002. Targeted gene expression in transgenic Xenopus using the binary Gal4-UAS system. Proc Natl Acad Sci U S A 99: 1377–1382. , , .
- 2002. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. Dev Biol 244: 305–318. , .
- 2001. Interaction of coxsackievirus B3 with the full length coxsackievirusadenovirus receptor. Nat Struct Biol 8: 874–878. , , , , , , , , , .
- 2006. Wnt/beta-catenin signaling regulates vertebrate limb regeneration. Genes Dev 20: 3232–3237. , , , , , , .
- 1995. Efficient hormone-inducible protein function in Xenopus laevis. Dev Biol 171: 267–272. , .
- 1984. Functional messenger RNAs are produced by Sp6 in vitro transcription of cloned cDNAs. Nucleic Acid Res 12: 7057–7070. , .
- 1996. Transgenic Xenopus embryos from sperm nuclear transplantations reveal FGF signaling requirements during gastrulation. Development 122: 3173–3183. , .
- 1998. Use of dominant negative constructs to modulate gene expression. Curr Top Dev Biol 36: 75–98. , .
- 2006. Gene silencing in Xenopus laevis byDNA vector-based RNA interference and transgenesis. Cell Res 16: 99–105. , .
- 2007. Regeneration of melanophores and other neural crest derivatives in the Xenopus tadpole tail. BMC Dev Biol 7: 56. , , .
- 1967. Normal table of Xenopus laevis (Daudin). Amsterdam: North-Holland. , .
- 2006. Highly efficient transgenesis in Xenopus tropicalis using I-SceI meganuclease. Mech Dev 123: 103–113. , , .
- 2006. I-SceI meganuclease-mediated transgenesis in Xenopus. Dev Dyn 235: 247–252. , , , , .
- 2002. A zebrafish coxsackievirus and adenovirus receptor homologue interacts with coxsackie B virus and adenovirus. J Virol 76: 10503–10506. , , , .
- 2004. The coxsackie-adenovirus receptor - a new receptor in the immunoglobulin family involved in cell adhesion. Curr Top Microbiol Immunol 273: 87–111. , .
- 2003. Tagging muscle cell lineages in development and tail regeneration using Cre recombinase in transgenic Xenopus. Nucleic Acids Res 31: 1044–1051. , , , , , .
- 2000. Early development of Xenopus laevis: a laboratory manual. Cold Spring Harbor New York: Cold Spring Harbor Laboratory Press. , , .
- 2005. Essential developmental biology. Oxford: Blackwell Science. .
- 2008. The Xenopus tadpole - a new model for regeneration research. Cell Molecular Life Sci 65: 54–63. , , .
- 2005. Characteristics of a thyroid hormone responsive reporter gene transduced into a Xenopus laevis cell line using lentivirus vector. Gen Comp Endocrinol 144: 270–279. , , .
- 2000. Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci U S A 97: 7963–7968. , , , , , .
- 2005. Gene therapy: twenty-first century medicine. Annu Rev Biochem 74: 711–738. , .
- 2006. Transgenic Xenopus laevis strain expressing Cre recombinase in muscle cells. Dev Dyn 235: 2220–2228. , , , , .
- 2001. FLP and Cre recombinase function in Xenopus embryos. Nucleic Acids Res 29: e53. , , .
- 2000. Inducible gene expression in transgenic Xenopus embryos. Curr Biol 10: 849–852. , , .